These findings provide new insight into the role of VAT in mediating obesity-induced endothelial dysfunction and suggest a novel role for CD36 as a mediator of endothelial Kir2.1 impairment. Here, CD36 is linked to obesity due to melanocortin 4 receptor deficiency.